Cellectar Biosc (NQ: CLRB )

1.740 USD -0.120 (-6.45%)

Official Closing Price Updated: 7:57 PM EST, Mar 4, 2021 Add to My Watchlist

Price and Volume

Volume	1,671,168
Open	1.840
Bid (Size)	1.700 (26)
Ask (Size)	1.790 (8)
Prev. Close	1.860
Today's Range	1.660 - 1.860
52wk Range	1.010 - 2.980
Shares Outstanding	17,708,558
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Cellectar Reports Financial Results for Year Ended December 31, 2020 and Provides a Corporate Update

March 02, 2021

Cellectar to Present at BIO CEO & Investor Digital Conference

February 10, 2021

Performance

YTD	-15.94%	-15.94%
1 Month	-16.75%	-16.75%
3 Month	-25.32%	-25.32%
6 Month	+59.63%	+59.63%
1 Year	-24.68%	-24.68%

More News

Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Waldenstrom’s Macroglobulinemia

January 27, 2021

AavantiBio Adds Veteran Life Sciences Executive Douglas J. Swirsky as Chief Financial Officer and Treasurer

March 03, 2021

Cellectar Initiates Pivotal Trial of CLR 131 in Waldenstrom’s Macroglobulinemia

January 12, 2021

3 Penny Stocks To Buy Under $2 & Analysts Have Targets Up To 367%

January 28, 2021

Cellectar Biosciences Announces Closing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement

December 28, 2020

Top Penny Stocks Insiders Decided To Buy Before 2021

January 03, 2021

Top Penny Stocks To Watch Before 2021 If You Like Biotech Stocks

December 27, 2020

InvestorNewsBreaks – Cellectar Biosciences Inc. (NASDAQ: CLRB) Secures $45M in Underwritten Public Offering and Concurrent Private Placement

January 06, 2021

12 Health Care Stocks Moving In Friday's After-Market Session

February 12, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.